![]() The global Retinal Implant Market size is expected to reach USD 112.2 million by 2030, registering a CAGR of 10.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of target diseases, and rising geriatric population are the key driving factors for the market. Rising capability of restoring vision is anticipated to bode well for demand over the forecast period. Laser therapy and Photodynamic Therapy (PTD) and some of the conventional treatments available for Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). Drugs such as Lucentis, Macugen, Eylea, and Vitamin A are a part of therapeutic treatment. Such treatments aid in reducing disease progression and thereby, delaying blindness. However, none of these treatments can completely cure the disease and restore vision. As a result, treatment procedures that restore vision are highly in demand. Currently approved devices are capable of restoring vision with the help of electrodes, camera chips, lenses, software, and other tools. Moreover, implantable miniature telescope, Argus II is easy to use and enables patients to carry out their daily activities with ease. Furthermore, these devices can be used for a prolonged period of time, eliminating the need for another surgery. Therefore, the capability of advanced implantable devices to restore vision is expected to propel the market growth in near future. Increasing geriatric population and rising disposable income in developing economies such as Japan, China, and India are also expected to boost the retinal implant market over the forecast period. Moreover, increasing healthcare expenditure by governments and private sectors and initiatives by major market players to operate in untapped regions are also anticipated to propel the growth in the forthcoming years. Related Press Release@ Retinal Implants Market Report List of Key Players of Retinal Implants Market
Grand View Research has segmented the global retinal implants market based on device type, and region: Retinal Implants Device Type Outlook (Revenue, USD Million, 2018 - 2030)
0 Comments
The global Dermatoscope Market size is expected to reach USD 2.0 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 12.1% during the forecast period. Dermatoscopy plays a vital role in screening for skin cancer, which has resulted in the early detection and identification of pigmented lesions. Benign pigmented moles possess a certain risk of developing melanoma.
The incidence of several skin conditions has increased during the COVID-19 pandemic. Contact dermatitis, pressure urticaria, pressure injury, itching, seborrheic dermatitis, acne, and worsening of pre-existing skin diseases. The Dermatology Practical & Conceptual conducted a survey on 678 dermatologists to investigate the impact of the coronavirus disease 2019 outbreak on the daily practice of dermatologists working with skin cancer patients. This survey stated that there was a 75% reduction in daily work activity and 118 dermatologists experienced telemedicine for the first time. However, with the ease in the restrictions, the aesthetic industry is again witnessing lucrative growth rate. Skin cancer is a chronic disease affecting a large population of the world. The rising incidence of melanoma and nonmelanoma skin cancers is providing an upthrust to the market. Certain moles, such as giant congenital pigmented hairy moles, are at high risk of developing melanoma. This has boosted the need for effective diagnosis with dermatoscopes. Early detection of skin cancer has been proven to be very useful in its effective treatment. Hence, a rising number of awareness campaigns is estimated to fuel the demand for dermatoscopes, which is anticipated to propel the market. Earlier, the usage of these technologically advanced devices was limited to the detection of noninvasive melanoma. However, with technological advancements, their application has widened to the advanced diagnosis of various skin disorders. North America region is currently the dominant region in terms of market share in dermatoscopes market. High prevalence of skin diseases, the presence of advanced healthcare infrastructure, presence of medical device manufacturers, and huge economic development are some of the major factors propels the North America dermatoscopes market. Related Press Release@ Dermatoscope Market Report Dermatoscope Market Report Highlights
Grand View Research has segmented the global dermatascope market based on product, technology, modality, end-use, and region: Dermatoscope Product Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Urinary Tract Infection Testing Market is expected to reach USD 812.01 million by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2030. The urinary tract infection (UTI) testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products. Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women. Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally. However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care. Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting. List of Key Players of Urinary Tract Infection Testing Market
Urinary Tract Infection Testing Market Highlights
Grand View Research has segmented the global urinary tract infection testing market on the basis of type, end-use, and region: Urinary Tract Infection Testing Type Outlook (Revenue, USD Million, 2018 - 2030)
|
Archives
October 2023
|